1. Indications and Usage
Diabetes Mellitus: As a second-line treatment for adult patients with type 2 diabetes mellitus who have not achieved adequate glycemic control with diet and exercise alone.
2. Dosage and Administration
Route: Oral administration.
Dosage: Standard dosage is twice daily. The maximum daily dosage must not exceed the recommended limits for individual components.
Timing: Take during meals to minimize gastrointestinal discomfort.
3. Mechanism of Action
Metformin: A biguanide that decreases hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.
Vildagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that increases the levels of incretin hormones, stimulating glucose-dependent insulin release and inhibiting glucagon secretion.
4. Safety and Warnings
Lactic Acidosis: A rare but serious complication associated with metformin accumulation; risk increases in renal impairment or hypoxic states.
Hypoglycemia: Risk may increase when combined with insulin or sulfonylureas.
Hypersensitivity: Severe allergic reactions, including angioedema, may occur.
Hepatic Impairment: Use with caution in patients with liver dysfunction.
5. Adverse Reactions and Clinical Research
Adverse Reactions: Common reactions include diarrhea, nausea, vomiting, headache, and abdominal pain.
Clinical Research: Clinical trials demonstrate that the combination therapy is effective in reducing fasting and postprandial glucose levels and HbA1c compared to monotherapy.
6. Drug Interactions
Alcohol: Potentiates the effect of metformin on lactate metabolism and increases the risk of lactic acidosis.
Cationic Drugs: Drugs like amiloride, digoxin, and morphine may interfere with metformin excretion.
Glucocorticoids and Diuretics: May increase blood glucose levels and alter glycemic control.
7. Pharmaceutical Information
Active Ingredients: Metformin hydrochloride and vildagliptin.
Excipients: Microcrystalline cellulose, povidone, and magnesium stearate.
Appearance: Film-coated tablets.
Storage: Store in a tightly sealed container, protected from moisture and light, below 30°C.

Jiasu Metformin Hydrochloride and Vildagliptin Tablets (II)
Brand Name:加苏®( Jiasu®)
Generic Name: Metformin Hydrochloride and Vildagliptin
Strength: Each tablet contains 850 mg metformin hydrochloride plus 50 mg vildagliptin, 30 tablets per bottle
Manufacturer: Yangtze River Pharmaceutical Group Co., Ltd.
Marketing Authorization Holder: Yangtze River Pharmaceutical Group Co., Ltd.
Approval Date in China: June 1, 2021
Registration Number:国药准字 H20213447
Storage: Seal tightly, store at ambient temperature below 30 ℃ in a dry place away from moisture; keep out of children’s reach, follow detailed storage guidance on the package insert.
Price&Cost:Contact Us now for the best price of Metformin Hydrochloride and Vildagliptin(Jiasu)
Only logged in customers who have purchased this product may leave a review.





Reviews
There are no reviews yet.